Slow-acting antirheumatic drugs in chronic arthritis of childhood - ScienceDirect

Seminars in Arthritis and Rheumatism

Volume 18, Issue 1, August 1988, Pages 38-47

Seminars in Arthritis and Rheumatism

https://doi.org/10.1016/0049-0172(88)90033-9 Get rights and content

First page preview

First page preview

Click to open first page preview

References (27)

A Shore et al.
Juvenile psoriatic arthritis—an analysis of 60 cases
J Pediatr
(1982)
M Hadchouel et al.
Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: Possible relationship to drugs or infection
J Pediatr
(1985)
ED Silverman et al.
Consumption coagulopathy associated with systemic juvenile rheumatoid arthritis
J Pediatr
(1983)
EH Giannini et al.
Auranofin in the treatment of juvenile rheumatoid arthritis
J Pediatr
(1983)
EJ Brewer et al.
Early experiences with auranofin in juvenile rheumatoid arthritis
Am J Med
(1983)
JC Jacobs et al.
Consumption coagulopathy after gold therapy for JRA
J Pediatr
(1984)
EJ Brewer et al.
Current proposed revision of JRA criteria
Arthritis Rheum
(1977)
E Sairanen et al.
The results of gold therapy in juvenile rheumatoid arthritis
Ann Pediatr Fenn
(1964)
E Sairanen et al.
The toxicity of gold therapy in children suffering from rheumatoid arthritis
Ann Pediatr Fenn
(1962)
RM Hicks et al.
The use of gold in the treatment of juvenile rheumatoid arthritis (JRA)
Arthritis Rheum
(1970)

C Debendetti et al.

Gold therapy in rheumatoid arthritis

Ariz Med

(1976)

JE Levinson et al.

Gold therapy

Arthritis Rheum

(1977)

EJ Brewer et al.

Gold therapy in the management of juvenile rheumatoid arthritis

Arthritis Rheum

(1980)

Cited by (0)

¹: From the Division of Rheumatology, Department of Pediatrics, University of British Columbia, Vancouver.

Copyright © 1988 Published by Elsevier Inc.